Citations (135)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Inge Compter, Danielle B. P. Eekers, Ann Hoeben, Kasper M. A. Rouschop, Bart Reymen, Linda Ackermans, Jan Beckervordersantforth, Noel J. C. Bauer, Monique M. Anten, Pieter Wesseling, Alida A. Postma, Dirk De Ruysscher & Philippe Lambin. (2021) Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial. Autophagy 17:9, pages 2604-2612.
Read now
Read now
Barry Jutten, Tom G. Keulers, Hanneke J. M. Peeters, Marco B. E. Schaaf, Kim G. M. Savelkouls, Inge Compter, Ruud Clarijs, Olaf E. M. G. Schijns, Linda Ackermans, Onno P. M. Teernstra, Marijke I. Zonneveld, Resi M. E. Colaris, Ludwig Dubois, Marc A. Vooijs, Johan Bussink, Julio Sotelo, Jan Theys, Guido Lammering & Kasper M. A. Rouschop. (2018) EGFRvIII expression triggers a metabolic dependency and therapeutic vulnerability sensitive to autophagy inhibition. Autophagy 14:2, pages 283-295.
Read now
Read now
Hai Liu, Weifang Yang, Huaping Gao, Tingting Jiang, Bengxin Gu, Qinghua Dong, Wenhong Xu, Shixiu Wu & Xiaonan Sun. (2015) Nimotuzumab abrogates acquired radioresistance of KYSE-150R esophageal cancer cells by inhibiting EGFR signaling and cellular DNA repair. OncoTargets and Therapy 8, pages 509-518.
Read now
Read now
Barry Jutten & Kasper rouschop. (2014) EGFR signaling and autophagy dependence for growth, survival, and therapy resistance. Cell Cycle 13:1, pages 42-51.
Read now
Read now
Brian M Alexander, Keith L Ligon & Patrick Y Wen. (2013) Enhancing radiation therapy for patients with glioblastoma. Expert Review of Anticancer Therapy 13:5, pages 569-581.
Read now
Read now
Brian M Alexander, Eudocia Q Lee, David A Reardon & Patrick Y Wen. (2013) Current and future directions for Phase II trials in high-grade glioma. Expert Review of Neurotherapeutics 13:4, pages 369-387.
Read now
Read now
H. Helen Lin, Xu Li, Jo-Lin Chen, Xiuzhu Sun, Fariba Norouziyan Cooper, Yun-Ru Chen, Wenyu Zhang, Yiyin Chung, Angela Li, Chun-Ting Cheng, Lixin Yang, XuTao Deng, Xiyong Liu, Yun Yen, Deborah L. Johnson, Hsiu-Ming Shih, Austin Yang & David K. Ann. (2012) Identification of an AAA ATPase VPS4B-Dependent Pathway That Modulates Epidermal Growth Factor Receptor Abundance and Signaling during Hypoxia. Molecular and Cellular Biology 32:6, pages 1124-1138.
Read now
Read now
Sarah E. Golding & Kristoffer Valerie. (2011) MRE11 and ATM AKTivate pro-survival signaling. Cell Cycle 10:19, pages 3227-3227.
Read now
Read now
Ashraf Khalil, Rhiannon N. Morgan, Bret R. Adams, Sarah E. Golding, Seth M. Dever, Elizabeth Rosenberg, Lawrence F. Povirk & Kristoffer Valerie. (2011) ATM-dependent ERK signaling via AKT in response to DNA double-strand breaks. Cell Cycle 10:3, pages 481-491.
Read now
Read now
Mechthild Krause, Kristin Gurtner, Yvonne Deuse & Michael Baumann. (2009) Heterogeneity of tumour response to combined radiotherapy and EGFR inhibitors: Differences between antibodies and TK inhibitors. International Journal of Radiation Biology 85:11, pages 943-954.
Read now
Read now
Articles from other publishers (125)
Hongjie Chen, Yangchan Hu, Zirui Zhuang, Dingyi Wang, Zu Ye, Ji Jing & Xiangdong Cheng. (2023) Advancements and Obstacles of PARP Inhibitors in Gastric Cancer. Cancers 15:21, pages 5114.
Crossref
Crossref
Fiona Brown-Burke, Inah Hwang, Shelby Sloan, Claire Hinterschied, JoBeth Helmig-Mason, Mackenzie Long, Wing Keung Chan, Alexander Prouty, Ji-Hyun Chung, Yang Zhang, Satishkumar Singh, Youssef Youssef, Neha Bhagwat, Zhengming Chen, Selina Chen-Kiang, Maurizio Di Liberto, Olivier Elemento, Lalit Sehgal, Lapo Alinari, Kris Vaddi, Peggy Scherle, Rosa Lapalombella, Jihye Paik & Robert A. Baiocchi. (2023) PRMT5 inhibition drives therapeutic vulnerability to combination treatment with BCL-2 inhibition in mantle cell lymphoma. Blood Advances 7:20, pages 6211-6224.
Crossref
Crossref
Sergio Corrales-Guerrero, Tiantian Cui, Veronica Castro-Aceituno, Linlin Yang, Sindhu Nair, Haihua Feng, Monica Venere, Stephanie Yoon, Todd DeWees, Changxian Shen & Terence M. Williams. (2023) Inhibition of RRM2 radiosensitizes glioblastoma and uncovers synthetic lethality in combination with targeting CHK1. Cancer Letters 570, pages 216308.
Crossref
Crossref
Junsheng Li, Siyu Wang, Qiheng He, Fa Lin, Chuming Tao, Yaowei Ding, Jia Wang, Jizong Zhao & Wen Wang. (2023) High ECM2 Expression Predicts Poor Clinical Outcome and Promotes the Proliferation, Migration, and Invasiveness of Glioma. Brain Sciences 13:6, pages 851.
Crossref
Crossref
Andreas Müller, Patrick Weyerhäuser, Nancy Berte, Fitriasari Jonin, Bogdan Lyubarskyy, Bettina Sprang, Sven Rainer Kantelhardt, Gabriela Salinas, Lennart Opitz, Walter Schulz-Schaeffer, Alf Giese & Ella L. Kim. (2023) Concurrent Activation of Both Survival-Promoting and Death-Inducing Signaling by Chloroquine in Glioblastoma Stem Cells: Implications for Potential Risks and Benefits of Using Chloroquine as Radiosensitizer. Cells 12:9, pages 1290.
Crossref
Crossref
Pavel Burko, Giuseppa D’Amico, Ilia Miltykh, Federica Scalia, Everly Conway de Macario, Alberto J. L. Macario, Giuseppe Giglia, Francesco Cappello & Celeste Caruso Bavisotto. (2023) Molecular Pathways Implicated in Radioresistance of Glioblastoma Multiforme: What Is the Role of Extracellular Vesicles?. International Journal of Molecular Sciences 24:5, pages 4883.
Crossref
Crossref
Amrita Sule, Sarah E. Golding, Syed F. Ahmad, James Watson, Mostafa H. Ahmed, Glen E. Kellogg, Tytus Bernas, Sean Koebley, Jason C. Reed, Lawrence F. Povirk & Kristoffer Valerie. (2022) ATM phosphorylates PP2A subunit A resulting in nuclear export and spatiotemporal regulation of the DNA damage response. Cellular and Molecular Life Sciences 79:12.
Crossref
Crossref
Lars Erichsen & James Adjaye. (2022) Crosstalk between age accumulated DNA-damage and the SIRT1-AKT-GSK3ß axis in urine derived renal progenitor cells. Aging.
Crossref
Crossref
Songwang Xie, Zhen Hong, Yan Li, Junyong Wang, Jian Wang, Shaoquan Li & Yongchang Liu. (2022) RNF216 Alleviates Radiation-Induced Apoptosis and DNA Damage Through Regulating Ubiquitination-Mediated Degradation of p53 in Glioblastoma. Molecular Neurobiology 59:8, pages 4703-4717.
Crossref
Crossref
Michel M. Ouellette, Sumin Zhou & Ying Yan. (2022) Cell Signaling Pathways That Promote Radioresistance of Cancer Cells. Diagnostics 12:3, pages 656.
Crossref
Crossref
Qiang Shi, Qiao-Na Shi, Jiang-Wei Xu, Hong-Yan Wang, Ya-Jie Li, Xin-Xin Zhang, Yu-Hang Fu, Ru-Hui Tian, Ru Jiang, Chun-Chun Liu & Chang Sun. (2022)
rs9390123 and rs9399451 influence the DNA repair capacity of lung cancer by regulating
PEX3
and
PHACTR2‑AS1
expression instead of
PHACTR2
. Oncology Reports 47:3.
Crossref
Crossref
A.S. Belyashova, M.V. Galkin, N.A. Antipina, G.V. Pavlova & A.V. Golanov. (2022) Cell cultures in assessing radioresistance of glioblastomas. Voprosy neirokhirurgii imeni N.N. Burdenko 86:5, pages 126.
Crossref
Crossref
Erica M. Stringer-Reasor, Jori E. May, Eva Olariu, Valerie Caterinicchia, Yufeng Li, Dongquan Chen, Deborah L. Della Manna, Gabrielle B. Rocque, Christos Vaklavas, Carla I. Falkson, Lisle M. Nabell, Edward P. Acosta, Andres Forero-Torres & Eddy S. Yang. (2021) An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer. Breast Cancer Research 23:1.
Crossref
Crossref
Yu Zhang, Yan Wang, Ding Zhou, Kai Wang, Xu Wang, Xiang Wang, Yang Jiang, Min Zhao, Rutong Yu & Xiuping Zhou. (2021) Radiation-induced YAP activation confers glioma radioresistance via promoting FGF2 transcription and DNA damage repair. Oncogene 40:27, pages 4580-4591.
Crossref
Crossref
Semer Maksoud. (2021) The Role of the Ubiquitin Proteasome System in Glioma: Analysis Emphasizing the Main Molecular Players and Therapeutic Strategies Identified in Glioblastoma Multiforme. Molecular Neurobiology 58:7, pages 3252-3269.
Crossref
Crossref
Ernest Osei, Pascale Walters, Olivia Masella, Quinton Tennant, Amber Fishwick, Eugenia Dadzie, Anmol Bhangu & Johnson Darko. (2019) A review of predictive, prognostic and diagnostic biomarkers for brain tumours: towards personalised and targeted cancer therapy. Journal of Radiotherapy in Practice 20:1, pages 83-98.
Crossref
Crossref
Kyung Yong Lee & Anindya Dutta. (2021) Chk1 promotes non-homologous end joining in G1 through direct phosphorylation of ASF1A. Cell Reports 34:4, pages 108680.
Crossref
Crossref
Xiaolong WeiJiekun YangSara J. Adair, Harun OzturkCem Kuscu, Kyung Yong Lee, William J. KanePatrick E. O’Hara, Denis LiuYusuf Mert Demirlenk, Alaa Hamdi HabiebEbru Yilmaz, Anindya Dutta, Todd W. Bauer & Mazhar Adli. (2020) Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells. Proceedings of the National Academy of Sciences 117:45, pages 28068-28079.
Crossref
Crossref
Ling Zeng, Drexell Hunter Boggs, Chuan Xing, Zhuo Zhang, Joshua C. Anderson, Narendra Wajapeyee, Chris Veale, Markus Bredel, Lewis Z. Shi, James A. Bonner, Christopher D. Willey & Eddy S. Yang. (2020) Combining PARP and DNA-PK Inhibitors With Irradiation Inhibits HPV-Negative Head and Neck Cancer Squamous Carcinoma Growth. Frontiers in Genetics 11.
Crossref
Crossref
Md Yousuf Ali, Claudia R. Oliva, Abu Shadat M. Noman, Bryan G. Allen, Prabhat C. Goswami, Yousef Zakharia, Varun Monga, Douglas R. Spitz, John M. Buatti & Corinne E. Griguer. (2020) Radioresistance in Glioblastoma and the Development of Radiosensitizers. Cancers 12:9, pages 2511.
Crossref
Crossref
Katheryn Begg & Mahvash Tavassoli. (2020) Inside the hypoxic tumour: reprogramming of the DDR and radioresistance. Cell Death Discovery 6:1.
Crossref
Crossref
Elena Makino, Lisa Marie Fröhlich, Tobias Sinnberg, Corinna Kosnopfel, Birgit Sauer, Claus Garbe & Birgit Schittek. (2020) Targeting Rad51 as a strategy for the treatment of melanoma cells resistant to MAPK pathway inhibition. Cell Death & Disease 11:7.
Crossref
Crossref
Wenjing Zai, Wei Chen, Yuxuan Han, Zimei Wu, Jiajun Fan, Xuyao Zhang, Jingyun Luan, Shijie Tang, Xin Jin, Xiang Fu, Hongjian Gao, Dianwen Ju & Hongrui Liu. (2020) Targeting PARP and autophagy evoked synergistic lethality in hepatocellular carcinoma. Carcinogenesis 41:3, pages 345-357.
Crossref
Crossref
Karthika D. Selvasaravanan, Nicole Wiederspohn, Amina Hadzalic, Hannah Strobel, Christel Payer, Andrea Schuster, Georg Karpel-Massler, Markus D. Siegelin, Marc-Eric Halatsch, Klaus-Michael Debatin & Mike-Andrew Westhoff. (2020) The limitations of targeting MEK signalling in Glioblastoma therapy. Scientific Reports 10:1.
Crossref
Crossref
Bryan G. Harder, Sen Peng, Christopher P. Sereduk, Andrej M. Sodoma, Gaspar J. Kitange, Joseph C. Loftus, Jann N. Sarkaria & Nhan L. Tran. (2019) Inhibition of phosphatidylinositol 3-kinase by PX-866 suppresses temozolomide-induced autophagy and promotes apoptosis in glioblastoma cells. Molecular Medicine 25:1.
Crossref
Crossref
Michel M. Ouellette & Ying Yan. (2019) Radiation‐activated prosurvival signaling pathways in cancer cells. Precision Radiation Oncology 3:3, pages 111-120.
Crossref
Crossref
Francesco Marampon, Carmela Ciccarelli & Bianca Maria Zani. (2019) Biological Rationale for Targeting MEK/ERK Pathways in Anti-Cancer Therapy and to Potentiate Tumour Responses to Radiation. International Journal of Molecular Sciences 20:10, pages 2530.
Crossref
Crossref
Nicholas Eustace, Joshua Anderson, Catherine Langford, Hoa Trummell, Patricia Hicks, John Jarboe, James Mobley, Anita Hjelmeland, James Hackney, Rune Pedersen, Kadia Cosby, G. Gillespie, James Bonner & Christopher Willey. (2019) Myristoylated alanine-rich C-kinase substrate effector domain phosphorylation regulates the growth and radiation sensitization of glioblastoma. International Journal of Oncology.
Crossref
Crossref
Mila Maidarti, Yvonne L Clarkson, Marie McLaughlin, Richard A Anderson & Evelyn E Telfer. (2019)
Inhibition of PTEN activates bovine non-growing follicles
in vitro
but increases DNA damage and reduces DNA repair response
. Human Reproduction 34:2, pages 297-307.
Crossref
Crossref
Mahmoud Toulany. (2019) Targeting DNA Double-Strand Break Repair Pathways to Improve Radiotherapy Response. Genes 10:1, pages 25.
Crossref
Crossref
John T. Leith, Shaker A. Mousa, Aleck Hercbergs, Hung-Yun Lin & Paul J. Davis. (2018) Radioresistance of cancer cells, integrin αvβ3 and thyroid hormone. Oncotarget 9:97, pages 37069-37075.
Crossref
Crossref
Martin Rupp, Zhor Senhaji Mouhri, Christopher Williams & Bertrand J. Jean-Claude. (2018) Molecular analysis of the dual targeting of the epidermal growth factor receptor and the O6-methylguanine-DNA methyltransferase with a double arm hybrid molecule. Oncotarget 9:80, pages 35041-35055.
Crossref
Crossref
Jeremy Karlin, Jasmine Allen, Syed F. Ahmad, Gareth Hughes, Victoria Sheridan, Rajesh Odedra, Paul Farrington, Elaine B. Cadogan, Lucy C. Riches, Antonio Garcia-Trinidad, Andrew G. Thomason, Bhavika Patel, Jennifer Vincent, Alan Lau, Kurt G. Pike, Thomas A. Hunt, Amrita Sule, Nicholas C.K. Valerie, Laura Biddlestone-Thorpe, Jenna Kahn, Jason M. Beckta, Nitai Mukhopadhyay, Bernard Barlaam, Sebastien L. Degorce, Jason Kettle, Nicola Colclough, Joanne Wilson, Aaron Smith, Ian P. Barrett, Li Zheng, Tianwei Zhang, Yingchun Wang, Kan Chen, Martin Pass, Stephen T. Durant & Kristoffer Valerie. (2018) Orally Bioavailable and Blood–Brain Barrier-Penetrating ATM Inhibitor (AZ32) Radiosensitizes Intracranial Gliomas in Mice. Molecular Cancer Therapeutics 17:8, pages 1637-1647.
Crossref
Crossref
Xingmei Zhang, Li Peng, Zhiman Liang, Zhewen Kou, Yue Chen, Guangwei Shi, Xiaowen Li, Yanling Liang, Fang Wang & Yusheng Shi. (2018) Effects of Aptamer to U87-EGFRvIII Cells on the Proliferation, Radiosensitivity, and Radiotherapy of Glioblastoma Cells. Molecular Therapy - Nucleic Acids 10, pages 438-449.
Crossref
Crossref
Jung Hee Park, Kyung Hee Jung, Soo Jung Kim, Zhenghuan Fang, Hong Hua Yan, Mi Kwon Son, Juyoung Kim, Yeo Wool Kang, Ji Eun Lee, Boreum Han, Joo Han Lim & Soon-Sun Hong. (2017) Radiosensitization of the PI3K inhibitor HS-173 through reduction of DNA damage repair in pancreatic cancer. Oncotarget 8:68, pages 112893-112906.
Crossref
Crossref
Lisa Gleißner, Marcel Kwiatkowski, Laura Myllynen, Pascal Steffen, Cordula Petersen, Kai Rothkamm, Hartmut Schlüter & Malte Kriegs. (2017) Analyzing the influence of kinase inhibitors on DNA repair by differential proteomics of chromatin-interacting proteins and nuclear phospho-proteins. Oncotarget 8:67, pages 110983-110993.
Crossref
Crossref
Xuetao Han, Xiaoying Xue, Huandi Zhou & Ge Zhang. (2017) A molecular view of the radioresistance of gliomas. Oncotarget 8:59, pages 100931-100941.
Crossref
Crossref
Kai Chen, Yajie Li, Hui Xu, Chunfeng Zhang, Zhiqiang Li, Wei Wang & Baofeng Wang. (2017) An analysis of the gene interaction networks identifying the role of PARP1 in metastasis of non-small cell lung cancer. Oncotarget 8:50, pages 87263-87275.
Crossref
Crossref
Kyung Yong Lee, Jun-Sub Im, Etsuko Shibata & Anindya Dutta. (2017) ASF1a Promotes Non-homologous End Joining Repair by Facilitating Phosphorylation of MDC1 by ATM at Double-Strand Breaks. Molecular Cell 68:1, pages 61-75.e5.
Crossref
Crossref
Huan Lin, Ze-Tan Chen, Xiao-Dong Zhu, Ling Li, Song Qu, Wei Zhao, Fang Su, Jing-Ni Wei, Zhong-Guo Liang, Qi-Yan Mo, Jiang-Bo Wu & Hui-Ling Meng. (2017) Serum CD166: A novel biomarker for predicting nasopharyngeal carcinoma response to radiotherapy. Oncotarget 8:38, pages 62858-62867.
Crossref
Crossref
Siyuan Yan, Ling Liu, Fengxia Ren, Quan Gao, Shanshan Xu, Bolin Hou, Yange Wang, Xuejun Jiang & Yongsheng Che. (2017) Sunitinib induces genomic instability of renal carcinoma cells through affecting the interaction of LC3-II and PARP-1. Cell Death & Disease 8:8, pages e2988-e2988.
Crossref
Crossref
Ara Kim Wiese, Marie Schluterman Burdine, Richard H. Turnage, Alan J. Tackett & Lyle J. Burdine. (2017) DNA-PKcs controls calcineurin mediated IL-2 production in T lymphocytes. PLOS ONE 12:7, pages e0181608.
Crossref
Crossref
Laura Annovazzi, Marta Mellai & Davide Schiffer. (2017) Chemotherapeutic Drugs: DNA Damage and Repair in Glioblastoma. Cancers 9:6, pages 57.
Crossref
Crossref
Shang Cai, Ya Li, Jin-Yu Bai, Zhi-Qing Zhang, Yin Wang, Yin-Biao Qiao, Xiao-Zhong Zhou, Bo Yang, Ye Tian & Cong Cao. (2017) Gαi3 nuclear translocation causes irradiation resistance in human glioma cells. Oncotarget 8:21, pages 35061-35068.
Crossref
Crossref
Hongfang Zhang, Jing Yue, Zhenzhen Jiang, Rongjing Zhou, Ruifei Xie, Yiping Xu & Shixiu Wu. (2017) CAF-secreted CXCL1 conferred radioresistance by regulating DNA damage response in a ROS-dependent manner in esophageal squamous cell carcinoma. Cell Death & Disease 8:5, pages e2790-e2790.
Crossref
Crossref
Murugan Kalimutho, Amanda L. Bain, Bipasha Mukherjee, Purba Nag, Devathri M. Nanayakkara, Sarah K. Harten, Janelle L. Harris, Goutham N. Subramanian, Debottam Sinha, Senji Shirasawa, Sriganesh Srihari, Sandeep Burma & Kum Kum Khanna. (2017)
Enhanced dependency of
KRAS
‐mutant colorectal cancer cells on
RAD
51‐dependent homologous recombination repair identified from genetic interactions in
Saccharomyces cerevisiae
. Molecular Oncology 11:5, pages 470-490.
Crossref
Crossref
Nan Liu, Lei Zhang, Zhen Wang, Yingduan Cheng, Pengxing Zhang, Xin Wang, Weihong Wen, Hongwei Yang, Hui Liu, Weilin Jin, Yongsheng Zhang & Yanyang Tu. (2016) MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9. Oncotarget 8:12, pages 19244-19254.
Crossref
Crossref
S. Oeck, K. Al-Refae, H. Riffkin, G. Wiel, R. Handrick, D. Klein, G. Iliakis & V. Jendrossek. (2017) Activating Akt1 mutations alter DNA double strand break repair and radiosensitivity. Scientific Reports 7:1.
Crossref
Crossref
L Hu, X Li, Q liu, J Xu, H Ge, Z Wang, H Wang, Z Wang, C Shi, X Xu, J Huang, Z Lin, R O Pieper & C Weng. (2016) UBE2S, a novel substrate of Akt1, associates with Ku70 and regulates DNA repair and glioblastoma multiforme resistance to chemotherapy. Oncogene 36:8, pages 1145-1156.
Crossref
Crossref
Jason M. Beckta, Bret R. Adams & Kristoffer Valerie. 2017. ATM Kinase. ATM Kinase
375
390
.
A. Affolter & J. Hess. (2016) Präklinische Modelle für Kopf-Hals-TumorenPreclinical models in head and neck tumors. HNO 64:12, pages 860-869.
Crossref
Crossref
Younghyun Lee, Huizi Keiko Li, Aya Masaoka, Shigeaki Sunada, Hirokazu Hirakawa, Akira Fujimori, Jac A. Nickoloff & Ryuichi Okayasu. (2016) The purine scaffold Hsp90 inhibitor PU-H71 sensitizes cancer cells to heavy ion radiation by inhibiting DNA repair by homologous recombination and non-homologous end joining. Radiotherapy and Oncology 121:1, pages 162-168.
Crossref
Crossref
Aurélie Henry, Marie-Julie Nokin, Natacha Leroi, François Lallemand, Jérémy Lambert, Nicolas Goffart, Patrick Roncarati, Elettra Bianchi, Paul Peixoto, Arnaud Blomme, Andrei Turtoi, Olivier Peulen, Yvette Habraken, Félix Scholtes, Philippe Martinive, Philippe Delvenne, Bernard Rogister, Vincent Castronovo & Akeila Bellahcène. (2016) New role of osteopontin in DNA repair and impact on human glioblastoma radiosensitivity. Oncotarget 7:39, pages 63708-63721.
Crossref
Crossref
Yuehong Wang, Ratnakar Singh, Liguang Wang, Monique Nilsson, Ruchitha Goonatilake, Pan Tong, Lerong Li, Uma Giri, Pamela Villalobos, Barbara Mino, Jaime Rodriguez-Canales, Ignacio Wistuba, Jing Wang, John V. Heymach & Faye M. Johnson. (2016)
Polo-like kinase 1 inhibition diminishes acquired resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer with
T790M
mutations
. Oncotarget 7:30, pages 47998-48010.
Crossref
Crossref
Viviane Silva, Florian Lafont, Houda Benhelli-Mokrani, Magali Breton, Philippe Hulin, Thomas Chabot, François Paris, Vehary Sakanyan & Fabrice Fleury. (2016) Rapid Diminution in the Level and Activity of DNA-Dependent Protein Kinase in Cancer Cells by a Reactive Nitro-Benzoxadiazole Compound. International Journal of Molecular Sciences 17:5, pages 703.
Crossref
Crossref
Marina Holler, Astrid Grottke, Katharina Mueck, Julia Manes, Manfred Jücker, H. Peter Rodemann & Mahmoud Toulany. (2016) Dual Targeting of Akt and mTORC1 Impairs Repair of DNA Double-Strand Breaks and Increases Radiation Sensitivity of Human Tumor Cells. PLOS ONE 11:5, pages e0154745.
Crossref
Crossref
Jen-Chung Ko, Jyh-Cheng Chen, Tai-Jing Wang, Hao-Yu Zheng, Wen-Ching Chen, Po-Yuan Chang & Yun-Wei Lin. (2016) Astaxanthin down-regulates Rad51 expression via inactivation of AKT kinase to enhance mitomycin C-induced cytotoxicity in human non-small cell lung cancer cells. Biochemical Pharmacology 105, pages 91-100.
Crossref
Crossref
Shyhmin Huang, H. Peter Rodemann & Paul M. Harari. 2016. Molecular Radio-Oncology. Molecular Radio-Oncology
45
87
.
Amrita Sule & Kristoffer Valerie. 2016. Strategies to Enhance the Therapeutic Ratio of Radiation as a Cancer Treatment. Strategies to Enhance the Therapeutic Ratio of Radiation as a Cancer Treatment
289
305
.
Mahmoud Toulany. 2016. Strategies to Enhance the Therapeutic Ratio of Radiation as a Cancer Treatment. Strategies to Enhance the Therapeutic Ratio of Radiation as a Cancer Treatment
253
287
.
Monica Mangoni, Mariangela Sottili, Chiara Gerini & Lorenzo Livi. 2016. Radiobiology of Glioblastoma. Radiobiology of Glioblastoma
139
153
.
Kiran Mahajan & Nupam P. Mahajan. (2015) Cross talk of tyrosine kinases with the DNA damage signaling pathways. Nucleic Acids Research 43:22, pages 10588-10601.
Crossref
Crossref
Nina Struve, Matthias Riedel, Alexander Schulte, Thorsten Rieckmann, Tobias J. Grob, Andreas Gal, Kai Rothkamm, Katrin Lamszus, Cordula Petersen, Ekkehard Dikomey & Malte Kriegs. (2015) EGFRvIII does not affect radiosensitivity with or without gefitinib treatment in glioblastoma cells. Oncotarget 6:32, pages 33867-33877.
Crossref
Crossref
Sabine Mueller & Daphne A. Haas-Kogan. (2015) WEE1 Kinase As a Target for Cancer Therapy. Journal of Clinical Oncology 33:30, pages 3485-3487.
Crossref
Crossref
O’neil W. Guthrie. (2015) Localization and distribution of neurons that co-express xeroderma pigmentosum-A and epidermal growth factor receptor within Rosenthal's canal. Acta Histochemica 117:8, pages 688-695.
Crossref
Crossref
Jason M. Beckta, Seth M. Dever, Nisha Gnawali, Ashraf Khalil, Amrita Sule, Sarah E. Golding, Elizabeth Rosenberg, Aarthi Narayanan, Kylene Kehn-Hall, Bo Xu, Lawrence F. Povirk & Kristoffer Valerie. (2015) Mutation of the BRCA1 SQ-cluster results in aberrant mitosis, reduced homologous recombination, and a compensatory increase in non-homologous end joining. Oncotarget 6:29, pages 27674-27687.
Crossref
Crossref
Fahime Faqihi, Ali Neshastehriz, Shokouhozaman Soleymanifard, Robabeh Shabani & Nazila Eivazzadeh. (2015) Radiation-induced bystander effect in non-irradiated glioblastoma spheroid cells. Journal of Radiation Research 56:5, pages 777-783.
Crossref
Crossref
Laura Myllynen, Marcel Kwiatkowski, Lisa Glei?ner, Britta Riepen, Konstantin Hoffer, Marcus Wurlitzer, Cordula Petersen, Ekkehard Dikomey, Kai Rothkamm, Hartmut Schl?ter & Malte Kriegs. (2015) Quantitative proteomics unveiled: Regulation of DNA double strand break repair by EGFR involves PARP1. Radiotherapy and Oncology 116:3, pages 423-430.
Crossref
Crossref
Melissa W. Y. Chua, Mike Z. Lin, Janet L. Martin & Robert C. Baxter. (2015) Involvement of the insulin-like growth factor binding proteins in the cancer cell response to DNA damage. Journal of Cell Communication and Signaling 9:2, pages 167-176.
Crossref
Crossref
Monal Mehta, Atif Khan, Shabbar Danish, Bruce G. Haffty & Hatem E. Sabaawy. (2015) Radiosensitization of Primary Human Glioblastoma Stem-like Cells with Low-Dose AKT Inhibition. Molecular Cancer Therapeutics 14:5, pages 1171-1180.
Crossref
Crossref
Jianghong Man, Jocelyn D. Shoemake, Tuopu Ma, Anthony E. Rizzo, Andrew R. Godley, Qiulian Wu, Alireza M. Mohammadi, Shideng Bao, Jeremy N. Rich & Jennifer S. Yu. (2015) Hyperthermia Sensitizes Glioma Stem-like Cells to Radiation by Inhibiting AKT Signaling. Cancer Research 75:8, pages 1760-1769.
Crossref
Crossref
Jung-Hee Lee, Seon-Joo Park, Seo-Yeon Jeong, Min-Ji Kim, Semo Jun, Hyun-Seo Lee, In-Youb Chang, Sung-Chul Lim, Sang Pil Yoon, Jeongsik Yong & Ho Jin You. (2015) MicroRNA-22 Suppresses DNA Repair and Promotes Genomic Instability through Targeting of MDC1. Cancer Research 75:7, pages 1298-1310.
Crossref
Crossref
Małgorzata Krajewska, Rudolf S. N. Fehrmann, Elisabeth G. E. de Vries & Marcel A. T. M. van Vugt. (2015) Regulators of homologous recombination repair as novel targets for cancer treatment. Frontiers in Genetics 6.
Crossref
Crossref
Gong‑Ping Wang & Xiao‑Fang Han. (2015) CD9 modulates proliferation of human glioblastoma cells via epidermal growth factor receptor signaling. Molecular Medicine Reports.
Crossref
Crossref
SI-YAN GUO, XIAO-DONG ZHU, LIAN-YING GE, SONG QU, LING LI, FANG SU & YA GUO. (2015) RNAi-mediated knockdown of the c-jun gene sensitizes radioresistant human nasopharyngeal carcinoma cell line CNE-2R to radiation. Oncology Reports 33:3, pages 1155-1160.
Crossref
Crossref
Jennifer A. Stanley & Eddy S. Yang. 2015. PARP Inhibitors for Cancer Therapy. PARP Inhibitors for Cancer Therapy
381
412
.
ASHLEY L. HEIN, MICHEL M. OUELLETTE & YING YAN. (2014) Radiation-induced signaling pathways that promote cancer cell survival (Review). International Journal of Oncology 45:5, pages 1813-1819.
Crossref
Crossref
Q. Liu, K. M. Turner, W. K. Alfred Yung, K. Chen & W. Zhang. (2014) Role of AKT signaling in DNA repair and clinical response to cancer therapy. Neuro-Oncology 16:10, pages 1313-1323.
Crossref
Crossref
Cristina Zahonero & Pilar Sánchez-Gómez. (2014) EGFR-dependent mechanisms in glioblastoma: towards a better therapeutic strategy. Cellular and Molecular Life Sciences 71:18, pages 3465-3488.
Crossref
Crossref
Prudence Donovan, Kathleen Cato, Roxane Legaie, Rumal Jayalath, Gemma Olsson, Bruce Hall, Sarah Olson, Samuel Boros, Brent A. Reynolds & Angus Harding. (2014) Hyperdiploid tumor cells increase phenotypic heterogeneity within Glioblastoma tumors. Mol. BioSyst. 10:4, pages 741-758.
Crossref
Crossref
Hui K. Gan, Anna N. Cvrljevic & Terrance G. Johns. (2013) The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered. FEBS Journal 280:21, pages 5350-5370.
Crossref
Crossref
Hideaki Ogiwara, Ayako Ui, Bunsyo Shiotani, Lee Zou, Akira Yasui & Takashi Kohno. (2013) Curcumin suppresses multiple DNA damage response pathways and has potency as a sensitizer to PARP inhibitor. Carcinogenesis 34:11, pages 2486-2497.
Crossref
Crossref
Jia Hu, Ning Wang & Ya-Jie Wang. (2013) XRCC3 and RAD51 Expression Are Associated with Clinical Factors in Breast Cancer. PLoS ONE 8:8, pages e72104.
Crossref
Crossref
Ann McCormack, Warren Kaplan, Anthony J. Gill, Nicholas Little, Raymond Cook, Bruce Robinson & Roderick Clifton-Bligh. (2012) MGMT expression and pituitary tumours: relationship to tumour biology. Pituitary 16:2, pages 208-219.
Crossref
Crossref
Han-Dong Wang. (2013) ERK and PI3K signaling cascades induce Nrf2 activation and regulate cell viability partly through Nrf2 in human glioblastoma cells. Oncology Reports.
Crossref
Crossref
Pierre Tennstedt, Robert Fresow, Ronald Simon, Andreas Marx, Luigi Terracciano, Cordula Petersen, Guido Sauter, Ekkehard Dikomey & Kerstin Borgmann. (2012) RAD51 overexpression is a negative prognostic marker for colorectal adenocarcinoma. International Journal of Cancer 132:9, pages 2118-2126.
Crossref
Crossref
A C Mueller, D Sun & A Dutta. (2012) The miR-99 family regulates the DNA damage response through its target SNF2H. Oncogene 32:9, pages 1164-1172.
Crossref
Crossref
RUIFAN XIE, HAI YANG, QUNGEN XIAO, FENG MAO, SUOJUN ZHANG, FEI YE, FENG WAN, BAOFENG WANG, TING LEI & DONGSHENG GUO. (2012) Downregulation of LRIG1 expression by RNA interference promotes the aggressive properties of glioma cells via EGFR/Akt/c-Myc activation. Oncology Reports 29:1, pages 177-184.
Crossref
Crossref
Fengxiang Wei, Judy Yan, Damu Tang, Xiaozeng Lin, Lizhi He, Yanyun Xie, Lijian Tao & Shaojuan Wang. (2013) Inhibition of ERK activation enhances the repair of double-stranded breaks via non-homologous end joining by increasing DNA-PKcs activation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1833:1, pages 90-100.
Crossref
Crossref
E. Aaron Runkle, Hongtao Zhang, Zheng Cai, Zhiqiang Zhu, Barry L. Karger, Shiaw-Lin Wu, Donald M. O'Rourke, Zhaocai Zhou, Qiang Wang & Mark I. Greene. (2012) Reversion of the ErbB malignant phenotype and the DNA damage response. Experimental and Molecular Pathology 93:3, pages 324-333.
Crossref
Crossref
Somaira Nowsheen, Khaled Aziz, Mihalis I. Panayiotidis & Alexandros G. Georgakilas. (2012) Molecular markers for cancer prognosis and treatment: Have we struck gold?. Cancer Letters 327:1-2, pages 142-152.
Crossref
Crossref
Olga Yu. Zolotarskaya, Alison F. Wagner, Jason M. Beckta, Kristoffer Valerie, Kenneth J. Wynne & Hu Yang. (2012) Synthesis of Water-Soluble Camptothecin–Polyoxetane Conjugates via Click Chemistry. Molecular Pharmaceutics 9:11, pages 3403-3408.
Crossref
Crossref
Jing Bai, Xiao-Guang Guo & Xiao-Ping Bai. (2012) Epidermal Growth Factor Receptor-Related DNA Repair and Radiation-Resistance Regulatory Mechanisms: A Mini-Review. Asian Pacific Journal of Cancer Prevention 13:10, pages 4879-4881.
Crossref
Crossref
Mahmoud Toulany, Kyung-Jong Lee, Kazi R. Fattah, Yu-Fen Lin, Brigit Fehrenbacher, Martin Schaller, Benjamin P. Chen, David J. Chen & H. Peter Rodemann. (2012) Akt Promotes Post-Irradiation Survival of Human Tumor Cells through Initiation, Progression, and Termination of DNA-PKcs–Dependent DNA Double-Strand Break Repair. Molecular Cancer Research 10:7, pages 945-957.
Crossref
Crossref
Gina Chun Kost, Steven R. Patierno, Sandra S. Wise, Amie L. Holmes, John Pierce WiseSr.Sr. & Susan Ceryak. (2012) Protein tyrosine phosphatase (PTP) inhibition enhances chromosomal stability after genotoxic stress: Decreased chromosomal instability (CIN) at the expense of enhanced genomic instability (GIN)?. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 735:1-2, pages 51-55.
Crossref
Crossref
Hui K. Gan, Antony W. Burgess, Andrew H. A. Clayton & Andrew M. Scott. (2012) Targeting of a Conformationally Exposed, Tumor-Specific Epitope of EGFR as a Strategy for Cancer Therapy. Cancer Research 72:12, pages 2924-2930.
Crossref
Crossref
Brian M. Alexander, Nancy Pinnell, Patrick Y. Wen & Alan D’Andrea. (2011) Targeting DNA repair and the cell cycle in glioblastoma. Journal of Neuro-Oncology 107:3, pages 463-477.
Crossref
Crossref
Bipasha Mukherjee, Nozomi Tomimatsu, Kaushik Amancherla, Cristel V. Camacho, Nandini Pichamoorthy & Sandeep Burma. (2012) The Dual PI3K/mTOR Inhibitor NVP-BEZ235 Is a Potent Inhibitor of ATM- and DNA-PKCs-Mediated DNA Damage Responses. Neoplasia 14:1, pages 34-IN8.
Crossref
Crossref
Naihan Xu, Yuanzhi Lao, Yaou Zhang & David A. Gillespie. (2012) Akt: A Double-Edged Sword in Cell Proliferation and Genome Stability. Journal of Oncology 2012, pages 1-15.
Crossref
Crossref
Henning Willers, Heike N. Pfäffle & Lee Zou. 2012. DNA Repair in Cancer Therapy. DNA Repair in Cancer Therapy
119
160
.
Minjmaa Minjgee, Mahmoud Toulany, Rainer Kehlbach, Klaudia Giehl & H. Peter Rodemann. (2011) K-RAS(V12) Induces Autocrine Production of EGFR Ligands and Mediates Radioresistance Through EGFR-Dependent Akt Signaling and Activation of DNA-PKcs. International Journal of Radiation Oncology*Biology*Physics 81:5, pages 1506-1514.
Crossref
Crossref
Yixue Gu, Shasha Fan, Binjie Liu, Guopei Zheng, Yanhui Yu, Yongmei Ouyang & Zhimin He. (2011) TCRP1 promotes radioresistance of oral squamous cell carcinoma cells via Akt signal pathway. Molecular and Cellular Biochemistry 357:1-2, pages 107-113.
Crossref
Crossref
Meng Wang, Fabian Morsbach, David Sander, Liliana Gheorghiu, Akash Nanda, Cyril Benes, Malte Kriegs, Mechthild Krause, Ekkehard Dikomey, Michael Baumann, Jochen Dahm-Daphi, Jeffrey Settleman & Henning Willers. (2011) EGF Receptor Inhibition Radiosensitizes NSCLC Cells by Inducing Senescence in Cells Sustaining DNA Double-Strand Breaks. Cancer Research 71:19, pages 6261-6269.
Crossref
Crossref
Mahmoud Toulany, Tim-Andre Schickfluß, Kazi R. Fattah, Kyung-Jong Lee, Benjamin P.C. Chen, Birgit Fehrenbacher, Martin Schaller, David J. Chen & H. Peter Rodemann. (2011) Function of erbB receptors and DNA-PKcs on phosphorylation of cytoplasmic and nuclear Akt at S473 induced by erbB1 ligand and ionizing radiation. Radiotherapy and Oncology 101:1, pages 140-146.
Crossref
Crossref
Amy J. Hawkins, Sarah E. Golding, Ashraf Khalil & Kristoffer Valerie. (2011) DNA double-strand break – induced pro-survival signaling. Radiotherapy and Oncology 101:1, pages 13-17.
Crossref
Crossref
Laura Myllynen, Thorsten Rieckmann, Jochen Dahm-Daphi, Ulla Kasten-Pisula, Cordula Petersen, Ekkehard Dikomey & Malte Kriegs. (2011) In tumor cells regulation of DNA double strand break repair through EGF receptor involves both NHEJ and HR and is independent of p53 and K-Ras status. Radiotherapy and Oncology 101:1, pages 147-151.
Crossref
Crossref
JingChen Lu, LiFang Yang, YongGuang Tao, LunQuan Sun & Ya Cao. (2011) Role of epidermal growth factor receptor in DNA damage repair. Chinese Science Bulletin 56:30, pages 3132-3137.
Crossref
Crossref
Massimo Squatrito & Eric C. Holland. (2011) DNA Damage Response and Growth Factor Signaling Pathways in Gliomagenesis and Therapeutic Resistance. Cancer Research 71:18, pages 5945-5949.
Crossref
Crossref
Somaira Nowsheen, James A. Bonner, Albert F. LoBuglio, Hoa Trummell, Alexander C. Whitley, Michael C. Dobelbower & Eddy S. Yang. (2011) Cetuximab Augments Cytotoxicity with Poly (ADP-Ribose) Polymerase Inhibition in Head and Neck Cancer. PLoS ONE 6:8, pages e24148.
Crossref
Crossref
Ulla Kasten-Pisula, Jarob Saker, Wolfgang Eicheler, Mechthild Krause, Ala Yaromina, Sönke Meyer-Staeckling, Benjamin Scherkl, Malte Kriegs, Burkhard Brandt, Reidar Grénman, Cordula Petersen, Michael Baumann & Ekkehard Dikomey. (2011) Cellular and Tumor Radiosensitivity is Correlated to Epidermal Growth Factor Receptor Protein Expression Level in Tumors Without EGFR Amplification. International Journal of Radiation Oncology*Biology*Physics 80:4, pages 1181-1188.
Crossref
Crossref
Ariel Bensimon, Ruedi Aebersold & Yosef Shiloh. (2011) Beyond ATM: The protein kinase landscape of the DNA damage response. FEBS Letters 585:11, pages 1625-1639.
Crossref
Crossref
Klaus Dittmann, Claus Mayer, Birgit Fehrenbacher, Martin Schaller, Rainer Kehlbach & H. Peter Rodemann. (2011) Nuclear epidermal growth factor receptor modulates cellular radio-sensitivity by regulation of chromatin access. Radiotherapy and Oncology 99:3, pages 317-322.
Crossref
Crossref
Zhaolu Kong, Pavithra Raghavan, Daxing Xie, Thomas Boike, Sandeep Burma, David Chen, Arup Chakraborty, Jer-Tsong Hsieh & Debabrata Saha. (2010) Epothilone B Confers Radiation Dose Enhancement in DAB2IP Gene Knock-Down Radioresistant Prostate Cancer Cells. International Journal of Radiation Oncology*Biology*Physics 78:4, pages 1210-1218.
Crossref
Crossref
Bipasha Mukherjee, Hak Choy, Chaitanya Nirodi & Sandeep Burma. (2010) Targeting Nonhomologous End-Joining Through Epidermal Growth Factor Receptor Inhibition: Rationale and Strategies for Radiosensitization. Seminars in Radiation Oncology 20:4, pages 250-257.
Crossref
Crossref
Jun Lin, Xing-Mei Zhang, Jin-Cheng Yang, Yong-Bin Ye & Shen-Qiu Luo. (2010) γ-Secretase Inhibitor-I Enhances Radiosensitivity of Glioblastoma Cell Lines by Depleting CD133+ Tumor Cells. Archives of Medical Research 41:7, pages 519-529.
Crossref
Crossref
Mingzhu Liu, Yong Yang, Can Wang, Lidong Sun, Chuanzhong Mei, Wantong Yao, Yonglei Liu, Yinghong Shi, Shuangjian Qiu, Jia Fan, Xiumei Cai & Xiliang Zha. (2010) The effect of epidermal growth factor receptor variant III on glioma cell migration by stimulating ERK phosphorylation through the focal adhesion kinase signaling pathway. Archives of Biochemistry and Biophysics 502:2, pages 89-95.
Crossref
Crossref
Bret R. Adams, Amy J. Hawkins, Lawrence F. Povirk & Kristoffer Valerie. (2010) ATM-independent, high-fidelity nonhomologous end joining predominates in human embryonic stem cells. Aging 2:9, pages 582-596.
Crossref
Crossref
Kimmo J. Hatanpaa, Sandeep Burma, Dawen Zhao & Amyn A. Habib. (2010) Epidermal Growth Factor Receptor in Glioma: Signal Transduction, Neuropathology, Imaging, and Radioresistance. Neoplasia 12:9, pages 675-684.
Crossref
Crossref
Malte Kriegs, Ulla Kasten-Pisula, Thorsten Rieckmann, Katharina Holst, Jarob Saker, Jochen Dahm-Daphi & Ekkehard Dikomey. (2010) The epidermal growth factor receptor modulates DNA double-strand break repair by regulating non-homologous end-joining. DNA Repair 9:8, pages 889-897.
Crossref
Crossref
Bret R. Adams, Sarah E. Golding, Raj R. Rao & Kristoffer Valerie. (2010) Dynamic Dependence on ATR and ATM for Double-Strand Break Repair in Human Embryonic Stem Cells and Neural Descendants. PLoS ONE 5:4, pages e10001.
Crossref
Crossref
Zhaolu Kong, Daxing Xie, Thomas Boike, Pavithra Raghavan, Sandeep Burma, David J. Chen, Amyn A. Habib, Arup Chakraborty, Jer-Tsong Hsieh & Debabrata Saha. (2010) Downregulation of Human DAB2IP Gene Expression in Prostate Cancer Cells Results in Resistance to Ionizing Radiation. Cancer Research 70:7, pages 2829-2839.
Crossref
Crossref
Ping-Yuan Lin, Hung-Jen Liu, Ming-Huei Liao, Ching-Dong Chang, Chi-I Chang, Hsueh-Ling Cheng, Jeng-Woei Lee & Wen-Ling Shih. (2010) Activation of PI 3-kinase/Akt/NF-κB and Stat3 signaling by avian reovirus S1133 in the early stages of infection results in an inflammatory response and delayed apoptosis. Virology 400:1, pages 104-114.
Crossref
Crossref
Mahmoud Toulany, Rainer Kehlbach, H. Peter Rodemann & Hossein Mozdarani. (2010) Radiocontrast media affect radiation-induced DNA damage repair in vitro and in vivo by affecting Akt signalling. Radiotherapy and Oncology 94:1, pages 110-116.
Crossref
Crossref
Urszula Florczak, Mahmoud Toulany, Rainer Kehlbach & H. Peter Rodemann. (2009) 2-Methoxyestradiol-induced radiosensitization is independent of SOD but depends on inhibition of Akt and DNA-PKcs activities. Radiotherapy and Oncology 92:3, pages 334-338.
Crossref
Crossref
Bipasha Mukherjee, Brian McEllin, Cristel V. Camacho, Nozomi Tomimatsu, Shyam Sirasanagandala, Suraj Nannepaga, Kimmo J. Hatanpaa, Bruce Mickey, Christopher Madden, Elizabeth Maher, David A. Boothman, Frank Furnari, Webster K. Cavenee, Robert M. Bachoo & Sandeep Burma. (2009) EGFRvIII and DNA Double-Strand Break Repair: A Molecular Mechanism for Radioresistance in Glioblastoma. Cancer Research 69:10, pages 4252-4259.
Crossref
Crossref